Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy

NCT05630937 is registered in ClinicalTrials.gov with Nerviano Medical Sciences as lead sponsor.

NCT NCT05630937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05630937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy
Lead sponsor
Nerviano Medical Sciences
Phase
Phase 1/2
Overall status
Terminated
Start date
November 13, 2020
Completion date
August 6, 2024
Enrollment
31 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable hepatocellular carcinoma (hcc)